Cargando…
Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas
SIMPLE SUMMARY: Epstein-Barr virus (EBV) is the first-discovered and important human tumor virus. It infects more than 90% of human population and induces various lymphomas. Development of specific targeted therapies is very critical for treatment of EBV-induced lymphomas, but it remains a great cha...
Autores principales: | Pei, Yonggang, Wong, Josiah H. Y., Robertson, Erle S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564798/ https://www.ncbi.nlm.nih.gov/pubmed/32916819 http://dx.doi.org/10.3390/cancers12092565 |
Ejemplares similares
-
Epstein–Barr Virus: Diseases Linked to Infection and Transformation
por: Jha, Hem C., et al.
Publicado: (2016) -
Epstein–Barr Virus History and Pathogenesis
por: Yu, Hui, et al.
Publicado: (2023) -
Transcriptome reprogramming of Epstein-Barr virus infected epithelial and B cells reveals distinct host-virus interaction profiles
por: Ma, Nian, et al.
Publicado: (2022) -
Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus
por: Saha, Abhik, et al.
Publicado: (2019) -
Epstein-Barr virus and Burkitt lymphoma
por: Rowe, Martin, et al.
Publicado: (2014)